Vorapaxar
Top View
- High-Resolution Crystal Structure of Human Protease-Activated Receptor 1
- Study Protocol
- 1 Pharmacodynamic Effects of Vorapaxar As An
- GI Tables for Anticoagulation Discontinuation & Colonoscopy
- Effect of Vorapaxar Alone and in Combination with Aspirin on Bleeding Time and Platelet Aggregation in Healthy Adult Subjects
- Preventative Medication List
- Direct Oral Anticoagulant Use: a Practical Guide to Common Clinical Challenges
- Management of Antithrombotic Agents in Patients Undergoing Flexible Bronchoscopy
- ATC-Index Mit DDD-Angaben Für Deutschland Im Jahre 2019
- Maintenance Drug List
- Recent Progress and Market Analysis of Anticoagulant Drugs
- Vitamin K Antagonist Oral Anticoagulants Clinical Pathway
- Platelet Concentrates from 5 Donors in ABO Blood-Group-Matched Plasma) Were Obtained from the Dutch Bloodbank (Sanquin)
- Dental Considerations in Patients Taking New Antiplatelet and Anticoagulant Drugs
- Vorapaxar Manufacturer: Merck Sharp & Dohme Corp Drug Class1-5
- Platelet Aggregation Inhibitors (PDF)
- Peripheral Arterial Disease
- Outcomes of Paediatric Drug Development from a Labeling